Cited by 70Protein Kinase Regulation and GTPase SignalingCellular transport and secretionMechanisms of cancer metastasis

RalBP1 is necessary for metastasis of human cancer cell lines

Open access
Wu, Zhong, Owens, Charles, Chandra, Nidhi, Popovic, Kay, Conaway, Mark, Theodorescu, Dan·2010·Neoplasia

Abstract

RalA expression in human prostate cancer is associated with cell migration and is necessary for bone metastasis. However, the downstream effectors of RalA that mediate these functions remain unclear. Here we examined cell migration after small interfering RNA-mediated depletion of Ral effectors Ral binding protein 1 (RalBP1/RLIP), exocyst complex component 2 (Sec5), and phospholipase D1 (PLD1) and found that RalBP1 and RalA depletion inhibited cell migration to a similar extent. Stable lentivirus short hairpin interfering RNA-mediated depletion of RalA and RalBP1 in PC3 human prostate cancer cells inhibited bone metastasis after intracardiac inoculation. Depletion of RalBP1 diminished orthotopic tumor growth of PC3 cells and inhibited spontaneous metastasis from this site. Interestingly, the expression of wild-type or RalA mutants deficient in RalBP1 binding was effective at rescuing the reduced metastatic capacity of RalA-depleted PC3 cells, suggesting that RalA depletion does not reduce this solely by diminished interaction with RalBP1. To determine whether the role of RalBP1 in metastasis is relevant beyond prostate cancer, we studied the requirement of RalBP1 expression in an experimental metastasis model of human bladder cancer, a tumor type with high RalBP1 expression. Depletion of RalBP1 in UMUC3 cells resulted in decreased lung colonization while having a minimal effect on subcutaneous tumor growth. Our studies are the first to suggest that the expression of RalBP1 is necessary for human cancer cell metastasis. Furthermore, we show that the requirement for RalA expression for manifestation of this phenotype is not entirely dependent on a RalA-RalBP1 interaction.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1593/neo.101080

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Smith SC, Oxford G, Baras AS, Owens C, Havaleshko D, Brautigan DL, Safo MK, and Theodorescu D (2007). Expression of ral GTPases, their effectors, and activators in human bladder cancer. Clin Cancer Res 13, 3803-3813.
  2. Oxford G, Owens CR, Titus BJ, Foreman TL, Herlevsen MC, Smith SC, and Theodorescu D (2005). RalA and RalB: antagonistic relatives in cancer cell migration. Cancer Res 65, 7111-7120.
  3. Gildea JJ, Seraj MJ, Oxford G, Harding MA, Hampton GM, Moskaluk CA, Frierson HF, Conaway MR, and Theodorescu D (2002). RhoGDI2 is an invasion and metastasis suppressor gene in human cancer. Cancer Res 62, 6418-6423.

Cited by

Sorted by citations

Authors
Wu, Z., Owens, C., Chandra, N., Popovic, K., Conaway, M., & Theodorescu, D.
Affiliations
University of Virginia (US)
Corresponding author
Theodorescu, Dan
Venue
Neoplasia
Publisher
Elsevier BV
Published
2010-12
Volume
12
Issue
12
Pages
1003-1012
ISSN
1476-5586 (ISSN-L)
OpenAlex
W1934430972
Cited by
70
References
1
Citations by year
2026: 2 · 2025: 3 · 2023: 3 · 2022: 6 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 3 · 2017: 5 · 2016: 2 · 2015: 5 · 2014: 2 · 2013: 3 · 2012: 10
FWCI
2.67
Type
journal article
Language
en
Open access
Locations
  • Neoplasia (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • National Institutes of Health (CA104106)
  • National Cancer Institute (P01CA104106, R01CA075115, CA 104106)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords
RALBP1, RalA, metastasis, prostate cancer, bone metastasis, bladder cancer, cell migration, exocyst complex, Sec5, phospholipase D1, lung colonization, orthotopic tumor growth
MeSH terms
Animals, Urinary Bladder Neoplasms, Bone Neoplasms, Cell Movement, Humans, Lung Neoplasms, Male, Mice, Nude, Neoplasm Metastasis, Neoplasm Transplantation, Phospholipase D, Prostatic Neoplasms, Transplantation, Heterologous, Blotting, Western, ATP-Binding Cassette Transporters, Reverse Transcriptase Polymerase Chain Reaction, GTPase-Activating Proteins, ral GTP-Binding Proteins, Vesicular Transport Proteins, RNA, Small Interfering, Cell Line, Tumor, Cell Proliferation, Mice, Inverted Repeat Sequences

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review